532 related articles for article (PubMed ID: 26993289)
1. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
3. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.
Sims EJ; Green MW; Mehta A
Diabetes Care; 2005 Jul; 28(7):1581-7. PubMed ID: 15983304
[TBL] [Abstract][Full Text] [Related]
4. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
6. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
[TBL] [Abstract][Full Text] [Related]
7. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
8. Sustained Coinfections with
Fischer AJ; Singh SB; LaMarche MM; Maakestad LJ; Kienenberger ZE; Peña TA; Stoltz DA; Limoli DH
Am J Respir Crit Care Med; 2021 Feb; 203(3):328-338. PubMed ID: 32750253
[No Abstract] [Full Text] [Related]
9. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
[TBL] [Abstract][Full Text] [Related]
11. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
[TBL] [Abstract][Full Text] [Related]
13. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis.
Brennan AL; Gyi KM; Wood DM; Johnson J; Holliman R; Baines DL; Philips BJ; Geddes DM; Hodson ME; Baker EH
J Cyst Fibros; 2007 Apr; 6(2):101-9. PubMed ID: 16844431
[TBL] [Abstract][Full Text] [Related]
14. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
17. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.
Maliniak ML; Stecenko AA; McCarty NA
J Cyst Fibros; 2016 May; 15(3):350-6. PubMed ID: 26610860
[TBL] [Abstract][Full Text] [Related]
19.
Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
[No Abstract] [Full Text] [Related]
20. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE
Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
